NEW Episode 286 · Season 1 Oct 19, 2026 · 31 min
The Clinical Trial Bottleneck Is Not Discovery | Scott Chetham (3/4)
The conversation then moves to the decisions that determine whether a trial succeeds: what to measure, whom to enroll, and when to measure it. Scott uses Amgen's osteoporosis strategy to show how a focused endpoint and staged market entry can outperform an attempt to capture everything at once.
Listener moments on the timeline Moments: 0
0:00 30:38